Predict your next investment

JumpCode company logo
HEALTHCARE | Biotechnology
jumpcodegenomics.com

See what CB Insights has to offer

Total Raised

$26.01M

About JumpCode

JumpCode offers CRISPR-mediated rRNA depletion kits to remove nucleic acids from sequencing workflows to improve sensitivity and performance.

JumpCode Headquarter Location

1160 Cape Aire Lane

Carlsbad, California, 92008,

United States

(858)336-4827

Latest JumpCode News

People in the News: New Appointments at Jumpcode Genomics, Quantum-Si, Quanterix, SeqWell, More

Apr 30, 2021

Save for later Jumpcode Genomics: Jon Armstrong, Kerri McWeeny, Jonathan Bell Jumpcode Genomics has appointed Jon Armstrong as vice president of research and development, Kerri McWeeny as vice president of marketing, and Jonathan Bell as vice president of sales. Armstrong most recently served as CSO for Cofactor Genomics, which he also cofounded. Prior to his role at Cofactor Genomics, Armstrong spent nearly a decade in Elaine Mardis' lab at the MCDonnell Genome Institute of Washington University in St. Louis, where he helped develop microarray, next-generation sequencing, molecular biology, and cancer genetics technologies. McWeeny previously served as a senior director in marketing at Illumina. She joined Illumina in 2012 and held leadership roles in global pricing strategy, marketing strategy, and communications throughout her tenure there. Prior to Illumina, she held commercial leadership roles at Mo Bio Laboratories and GenVault Corp, as well as research and development roles at Motorola Life Sciences and Abbott Laboratories. Bell has held positions in sales, product marketing, and regional marketing for life sciences companies such as Affymetrix, Illumina, and 10x Genomics. He most recently served as a VP for Celsee, before it was acquired by Bio-Rad. Quantum-Si: Michael Mina Single-molecular proteomics firm Quantum-Si has appointed Michael Mina as chief medical advisor. Mina is assistant professor of epidemiology, immunology, infectious diseases, and pathology at the Harvard TH Chan School of Public Health and Harvard Medical School. He is also a professor and associate medical director in clinical pathology at Brigham and Women's Hospital at Harvard Medical School. He holds an MD and PhD from Emory University and competed his postdoc in infectious diseases at Princeton University and Harvard Med. Quanterix: Laurie Olson Quanterix has appointed Laurie Olson to its board of directors effective April 27. Olson most recently served as executive vice president for strategy and commercial operations at Pfizer and a member of Pfizer's executive leadership team until 2018. She currently serves on the board of directors of Karuna Therapeutics. SeqWell: Dan Calvo SeqWell, a Beverly, Massachusetts-based provider of next-generation sequencing library construction technologies, has named appointed Dan Calvo as president and CEO, effective April 19. Calvo most recently served as president and and CEO of Gyros Protein Technologies from 2013 through its acquisition by Mesa Labs in 2019. Prior to that, he was president and CEO of Oncimmune from 2009 to 2013. Calvo also previously served as CEO at Cellomics and Assay Designs, through their acquisitions by Fisher Scientific an Enzo Biochem, respectively. For additional recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing JumpCode

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

JumpCode is included in 1 Expert Collection, including Synthetic Biology.

S

Synthetic Biology

235 items

Companies involved in design and development of new biological parts, devices, and systems; as well as the re-design of existing biological systems.

JumpCode Patents

JumpCode has filed 5 patents.

The 3 most popular patent topics include:

  • DNA
  • Genetics
  • Molecular biology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/25/2016

4/6/2021

Molecular biology, Genetics, DNA, Biotechnology, DNA sequencing

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

2/25/2016

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

4/6/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Molecular biology, Genetics, DNA, Biotechnology, DNA sequencing

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

JumpCode Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

JumpCode Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.